1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Watch Out Neuro The Lawyers are calling

Discussion in 'NeuroMetrix' started by Anonymous, Aug 27, 2008 at 9:01 PM.

  1. Anonymous

    Anonymous Guest

    I got a call today from a Lawyer representing doctors and shareholders! Beware!
     
  2. Anonymous

    Anonymous Guest

    I'm surprised it's taken this long for them to come after Neuro. Just shows how well the company fed it's bullshit to everyone.
     
  3. Anonymous

    Anonymous Guest

    Well, did we settle? Are we out of the woods yet?
     
  4. Anonymous

    Anonymous Guest

    They still have sales reps?! HS!